New and Updated Clinical Influenza Vaccine Trials
-
COVID-19 Pharmacotherapy Effectiveness in the VA Healthcare System
Dec 7, 2023 | 06:00 amConditions: COVID-19, SARS-CoV-2 Infection; COVID-19, SARS-CoV-2 Infection, RSV, Influenza Sponsors: VA Office of Research and Development; Department of Health and Human Services; Food and Drug Administration (FDA) Recruiting
-
Influenza Viral Challenge Study of CC-42344 in Healthy Participants
Dec 7, 2023 | 06:00 amConditions: Influenza A Interventions: Drug: CC-42344; Drug: Placebo Sponsors: Cocrystal Pharma, Inc.; hVIVO Services Limited Recruiting
-
Improved Immunology Outcomes Associated With Lactoferrin Fortified With HMO in Infant Formula
Dec 6, 2023 | 06:00 amConditions: Flu; Cold Interventions: Dietary Supplement: Feihe Investigational Formula; Dietary Supplement: Control Formula; Other: Breastfeeding Sponsors: Heilongjiang Feihe Dairy Co. Ltd. Recruiting
-
Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos
Dec 5, 2023 | 06:00 amConditions: Vaccine Hesitancy Interventions: Behavioral: Multilevel Intervention Sponsors: San Diego State University Not yet recruiting
-
Community Care Intervention to Decrease COVID-19 Vaccination Inequities
Dec 5, 2023 | 06:00 amConditions: COVID-19 Vaccination Interventions: Behavioral: Community Health Worker Intervention to Enhance Vaccination Behavior (CHW-VB) Sponsors: RAND; Clinical Directors Network; National Institute on Minority Health and Health Disparities (NIMHD) Recruiting
-
Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia
Dec 4, 2023 | 06:00 amConditions: Leukemia; Stem Cell Transplant; Cord Blood Interventions: Procedure: applying of FLU+CY post-HSCT Sponsors: Nanfang Hospital, Southern Medical University Recruiting
-
CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101
Nov 30, 2023 | 06:00 amConditions: Idiopathic Inflammatory Myopathies; Diffuse Cutaneous Systemic Sclerosis; SLE Nephritis; ANCA Associated Vasculitis Interventions: Drug: KYV-101; Drug: Cyclophosphamide; Drug: Fludarabine Sponsors: David Porter; Kyverna Therapeutics Not yet recruiting
-
Efficacy of Probiotics (LiveSpo Navax) in Preventing Respiratory Diseases in Children
Nov 28, 2023 | 06:00 amConditions: Respiratory Disease; Respiratory Infections in Children Interventions: Drug: 0.9% NaCl physiological saline; Combination Product: Probiotic 1; Combination Product: Probiotic 2 Sponsors: Anabio R&D; Hanoi Medical University Not yet recruiting
